Mechanisms of disease: Roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage

Nature Clinical Practice Cardiovascular Medicine

Volumn 1, Issue 2, 2004, Pages 110-116

  Suhardja, Agustinus ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cerebral vasospasm; Endothelin 1; Nitric oxide; Subarachnoid hemorrhage; Vascular biology

Indexed keywords

ALTEPLASE; ANTISENSE OLIGODEOXYNUCLEOTIDE; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN 1; GLYCERYL TRINITRATE; MONOCLONAL ANTIBODY; NIMODIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL STIMULATING AGENT; RECOMBINANT ERYTHROPOIETIN;

ADRENERGIC SYSTEM; BLOOD CLOT LYSIS; BLOOD PRESSURE; BLOOD VOLUME; BRAIN ARTERY ANEURYSM; BRAIN PROTECTION; BRAIN VASOSPASM; CLINICAL FEATURE; DISEASE MODEL; DRUG ACTIVITY; HEMODYNAMICS; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SUBARACHNOID HEMORRHAGE; SYMPTOMATOLOGY;

ENDOTHELIN-1; HUMANS; INTRACRANIAL ANEURYSM; NITRIC OXIDE; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOSPASM, INTRACRANIAL;

EID: 20444459839     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0046     Document Type: Review

References (50)

1. Ecker A and Riemenschneider PA (1951) Arteriographic demonstration of spasm of the intracranial arteries. J Neurosurg 8: 660-667
2. Allcock JM and Drake CG (1965) Ruptured intracranial aneurysms: the role of arterial spasm. J Neurosurg 22: 21-29
3. Weir B et al. (1978) Time course of vasospasm in man. J Neurosurg 48: 173-178
4. Nornes H (1973) The role of intracranial pressure in the arrest of hemorrhage in patients with ruptured intracranial aneurysm. J Neurosurg 39: 226-234
5. Pluta RM et al. (1997) Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 87: 287-293
6. Dreier JP et al. (2000) Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 93: 658-666
7. Kleeberg J et al. (2004) ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol 286: H1339-H1346
8. Bian K and Murad F (2003) Nitric oxide (NO) - biogeneration, regulation, and relevance to human diseases. Front Biosci 8: 264-278
9. Buchanan JE and Phyllis JW (1993) The role of nitric oxide in the regulation of cerebral blood flow. Brain Res 610: 248-255
10. Pluta R et al. (1997) Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin and methemoglobin in subarachnoid hemorrhage. J Neurosurg 88: 557-561
11. Foley PL et al. (1993) Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection. Acta Neurochir 123: 82-86
12. Iuliano B et al. (2004) Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg 100: 287-294
13. Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376
14. Jung CS et al. (2004) Association between cerebrospinal fluid levels of asymmetric dimetyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 101: 733-740
15. Faraci FM et al. (1995) Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol 269: 1522-1527
16. Pluta R et al. (1996) Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84: 648-654
17. Brayden JE et al. (1991) Endothelium-dependent dilatation of feline cerebral arteries: role of membrane potential and cyclic-nucleotide. J Cereb Blood Flow Metab 9: 256-263
18. Zuccarello M et al. (1998) Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 29: 1924-1929
19. Toda N et al. (2000) Cerebral vasodilatation induced by stimulation of the sphenopalatine ganglion and greater petrosal nerve in anesthesized monkeys. Neuroscience 96: 393-398
20. Kwan AL et al. (1997) Inhibition of nitric oxide generation and lipid peroxidation attenuates hemolysate-induced injury to cerebrovascular endothelium. Acta Neurochir 139: 240-248
21. Steele JA et al. (1991) Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ Res 68: 416-423
22. Suzuki S et al. (1995) Hemin activation of an inducible isoform of nitric oxide synthase in vascular smooth-muscle cells. J Neurosurg 83: 862-866
23. Macdonald RL et al. (2004) Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs. Life Sci 75: 979-989
24. Vollrath B et al. (1995) Lazaroids and deferoxamine attenuate the intracellular effects of oxyhemoglobin in vascular smooth muscle. Cardiovasc Res 30: 619-826
25. Kajita Y et al. (1994) Combined affect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 80: 476-483
26. Tosaka M et al. (2002) Contractile responses to reactive oxygen species in the canine basilar artery in vitro: selective inhibitory effect of MCI-186, a new hydroxyl radical scavenger. Acta Neurochir 144: 1305-1310
27. Gaetani P et al. (1997) Superoxide dismutase activity in cisternal cerebrospinal fluid after subarachnoid hemorrhage. Acta Neurochir 139: 1033-1037
28. Hurairah H and Ferro A (2004) The role of endothelium in the control of vascular function. Inf J Clin Pract 58: 173-183
29. Juvela S (2000) Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg 92: 390-400
30. Seifert V et al. (1995) Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: correlation with cerebral vasospasm, delayed ischemic deficits, and volume of hematoma. J Neurosurg 82: 55-62
31. Petzold GC et al. (2003) Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol 54: 591-598
32. Mascia L et al. (2001) Temporal relationship between endethelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Stroke 32: 1185-1190
33. Fujimori A et al. (1989) Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Lancet 336: 633
34. Masaoka H et al. (1989) Raised plasma endothelin in aneurysmal subarachnoid hemorrhage. Lancet 336: 1402
35. Ehrenreich H et al. (1992) Long-term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 192: 257-268
36. Suzuki K et al. (2000) Endothelin-1 concentration increases in the cerebrospinal fluid in cerebral vasospasm caused by subarachnoid hemorrhage. Surg Neurol 53: 131-135
37. Hino A et al. (1996) Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 16: 688-697
38. Thorin E et al. (1998) Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke 29: 175-180
39. Ohnishi M et al. (2002) Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure. Clin Sci (London) 103 (suppl 48): 241S-244S
40. Warner TD et al. (1989) Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 13 (Suppl 5): S85-S88
41. Ohkita M et al. (2002) Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci (London) 103 (suppl 48): 68S-71S
42. Kosnik EJ and Hunt WE (1976) Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 45: 148-154
43. Kassell NF et al. (1982) Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11: 337-343
44. Chen AF et al. (1997) Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries. Proc Natl Acad Sci U S A 94: 12568-12573
45. Onoue H et al. (1998) Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29: 1959-1965
46. Wolf EW et al. (1998) Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg 89: 279-288
47. Pluta RM et al. (1997) Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87: 746-751
48. Ohkuma H et al. (1999) Antisense preproendothelin-oligo DNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 90: 1105-1114
49. Yamaura I et al. (1992) Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 76: 99-105
50. Caner HH et al. (1996) Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg 85: 917-922